News Briefs AstraZeneca spinout Entasis gets $50 mln to fight drug-resistant bacteria Lawrence Aragon - 4 April 2016 Share A- A+ 100% Create an account to continue reading Gain instant access to our expert editorial analysis and in-depth insight. Register for free Already have an account? Sign in
